This new GLP-1 play is on a tear. UBS sees nearly a 50% gain from here

Cnbc · May 12, 2026 · 250 words · By Liz Napolitano

Investment Opportunity Market Growth Biotech Innovation

headphones Listen to the eFinder podcast briefing

Generate a natural audio summary of this story

Daily briefing

What to know about Investment Opportunity

MBX Biosciences has more than tripled over the past year, but there's likely more to go as the biotech makes progress on developing a new GLP-1 treatment, according to UBS.

Claims checked 9

Techniques found 2

Topics 3

Coverage spectrum

Coverage gap: Low Left coverage

Left0%

Center100%

Right0%

2 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

MBX Biosciences has more than tripled over the past year, but there's likely more to go as the biotech makes progress on developing a new GLP-1 treatment, according to UBS.

Why it matters

The investment bank has a buy rating on MBX, and in a report out Monday left a $60 price target on the stock, implying nearly 50% upside from Friday's close.

Common ground

"The data looks positive and promising with early proof of concept and competitive on efficacy and… improved tolerability – which is key," analyst Michael Yee said Monday in a note to clients, referring to new data from MBX Biosciences' ongoing GLP-1 and…

Perspective signals

The tension in the story is sharpened by Loaded Language, Manufactured Consensus: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

Follow-up questions

What new context would change how readers understand this Investment Opportunity story?
What evidence would most clearly confirm or weaken the claim that Shares have surged more than 230% over the past year?
How does this story connect Investment Opportunity with Market Growth over the next few days?

open_in_new Read the original article: https://www.cnbc.com/2026/05/12/this-new-glp-1-play-is-on-a-tear-ubs-sees-nearly…

psychologyPropaganda Techniques Detected

eFinder identified 2 propaganda techniques in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning

Loaded Language 80% confidence

Using words with strong emotional connotations to influence an audience.

Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.

Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

warning

Manufactured Consensus 70% confidence

Creating an illusion of widespread agreement that does not exist.

Why it matters: Recognizing manufactured consensus helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 9 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

info Single Source 4

check_circle Corroborated 2

verified Verified 1

help Insufficient Evidence 1

verified Verified By Reference 1

check_circle

Claim 1: “Shares have surged more than 230% over the past year”

CORROBORATED

Investing.com reports a 440.59% change and another source reports a 255% gain over the past year; both figures are greater than 230%.

menu_book

wikipedia NEUTRAL — Cannabinoid receptors, located throughout the body, are part of the endocannabinoid system of vertebrates– a class of cell membrane receptors in the G protein-coupled receptor superfamily. As is typic…
https://en.wikipedia.org/wiki/Cannabinoid_receptor

menu_book

wikipedia NEUTRAL — This list of pharmaceutical compound number prefixes provides codes used by individual pharmaceutical companies when naming their pharmaceutical drug candidates. Pharmaceutical companies generally pro…
https://en.wikipedia.org/wiki/List_of_pharmaceutical_compoun…

menu_book

wikipedia NEUTRAL — Oleamide is an organic compound with the formula CH3(CH2)7CH=CH(CH2)7CONH2. It is the amide derived from the fatty acid oleic acid. It is a colorless waxy solid and occurs in nature. Sometimes labeled…
https://en.wikipedia.org/wiki/Oleamide

+ 3 more evidence sources

info

Claim 2: “The investment bank [UBS] has a buy rating on MBX”

SINGLE SOURCE

Only one specific web result ('UBS reiterates Buy on MBX Biosciences stock') mentions the buy rating. Other UBS results are general company descriptions.

travel_explore

web search NEUTRAL — Starting on 9 June 2003, all UBS business groups, including UBS Paine Webber and UBS Warburg, were rebranded under the UBS moniker following company's start of operations as a unified global entity.
https://en.wikipedia.org/wiki/UBS

travel_explore

web search NEUTRAL — UBS is a global firm providing financial services in over 50 countries. Visit our site to find out what we offer.
https://www.ubs.com/

travel_explore

web search NEUTRAL — In June 2023, Credit Suisse became a UBS Group company. With our large and diverse team operating internationally, we have a presence in all major financial centers in more than 50 countries.
https://www.linkedin.com/company/ubs

info

Claim 3: “The global market for those drugs could hit $190 billion by 2035, according to a recent report from Morgan Stanley”

SINGLE SOURCE

No evidence was found in the provided search results that mentions a Morgan Stanley report projecting a $190 billion market by 2035.

travel_explore

web search NEUTRAL — Type 2 diabetes makes up approximately 95% of diabetes cases and is more common in adults. Overweight individuals are particularly at risk of developing type 2 diabetes.
https://worldpopulationreview.com/country-rankings/diabetes-…

travel_explore

web search NEUTRAL — The global presence that Morgan Stanley maintains is key to our clients' success, giving us keen insight across regions and markets, and allowing us to make a difference around the world. Since our fo…
https://www.morganstanley.com/

travel_explore

web search NEUTRAL — Oral diabetes drugs such as metformin (Glumetza, Fortamet, others) may lower the risk of type 2 diabetes. But healthy lifestyle choices are important. If you have prediabetes, have your blood sugar ch…
https://www.mayoclinic.org/diseases-conditions/diabetes/symp…

check_circle

Claim 4: “MBX Biosciences has more than tripled over the past year”

CORROBORATED

Investing.com reports a 440.59% change over the past year, and another source mentions a 255% gain. Both independently confirm the stock has more than tripled (increased by >200%).

menu_book

+ 3 more evidence sources

verified

Claim 5: “MBX Biosciences' ongoing GLP-1 and glucose-dependent insulinotropic polypeptide receptor (GIPR) phase-one obesity study”

VERIFIED

BioSpace confirms MBX 4291 is an investigational long-acting GLP-1/GIP receptor co-agonist prodrug in development for obesity.

travel_explore

web search NEUTRAL — Dec 27, 2025 · Search all David Buchanan Obituaries and Death Notices to find upcoming funeral home services, leave condolences for the family, and research genealogy.
https://www.legacy.com/obituaries/name/buchanan/david

travel_explore

web search NEUTRAL — Father David Cleburn Buchanan, a priest of the Diocese of Birmingham, passed away March 6 at the age of 58. He was born June 13, 1955 in Guntersville to Leona (Kelley) and Cleburn Buchanan and was ...
https://www.legacy.com/obituaries/name/david-buchanan-obitua…

travel_explore

web search NEUTRAL — Feb 22, 2025 · David Buchanan Obituary It is with heavy hearts that we announce the passing of David Buchanan, who left us peacefully in his final days surrounded by loved ones on February 21st, 2025.…
https://www.legacy.com/us/obituaries/name/david-buchanan-obi…

help

Claim 6: “10 of 11 analysts covering MBX rate it a buy or strong buy”

INSUFFICIENT EVIDENCE

No evidence was provided or found regarding the specific number of analysts (10 of 11) rating the stock as buy or strong buy.

info

Claim 7: “MBX Biosciences' GLP-1 was slightly more effective at four weeks than tirzepatide, the active ingredient in Eli Lilly 's Zepbound”

SINGLE SOURCE

While BioSpace confirms the existence of the GLP-1/GIP drug (MBX 4291), none of the provided evidence compares its four-week efficacy specifically against tirzepatide/Zepbound.

travel_explore

web search NEUTRAL — Treatment was added to background therapy with basal insulin, with or without up to two oral glucose-lowering medications. A higher percentage of participants in the tirzepatide group achieved an A1C …
https://www.uptodate.com/contents/glucagon-like-peptide-1-ba…

travel_explore

web search NEUTRAL — Mazdutide and tirzepatide share dual GIP/GLP-1 mechanisms but differ critically in receptor binding affinity, half-life, and clinical trial data.
https://www.realpeptides.co/mazdutide-vs-tirzepatide-key-dif…

travel_explore

web search NEUTRAL — About MBX 4291 MBX 4291 is an investigational long-acting GLP-1/GIP receptor co-agonist prodrug in development as a potential treatment for obesity.
https://www.biospace.com/press-releases/mbx-biosciences-anno…

info

Claim 8: “in a report out Monday left a $60 price target on the stock”

SINGLE SOURCE

The $60 price target is mentioned in one specific web search result ('UBS reiterates Buy on MBX Biosciences stock, keeps $60 target'). Other analyst targets mentioned in Yahoo Finance and MarketBeat are different ($20-$62.55 range, average $37.50), but they do not contradict the existence of the UBS target.

travel_explore

web search NEUTRAL — UBS noted that MBX trades at approximately $1.5 billion market capitalization. The company’s stock currently trades at $37.37, reflecting a remarkable 255% gain over the past year, though shares have …
https://www.investing.com/news/analyst-ratings/ubs-reiterate…

travel_explore

web search NEUTRAL — Find the latest MBX Biosciences, Inc. (MBX) stock quote, history, news and other vital information to help you with your stock trading and investing.Analyst Price Targets. 20.00. 62.55 Average. 29.60 …
https://finance.yahoo.com/quote/MBX/

travel_explore

web search NEUTRAL — MBX's current price target is $37.50. Learn why top analysts are making this stock forecast for MBX Biosciences at MarketBeat.
https://www.marketbeat.com/stocks/NYSE/MBX/forecast/

verified

Claim 9: “Type-2 diabetes and obesity treatments raked in a combined $79 billion in sales in 2025”

VERIFIED BY REFERENCE

The provided evidence mentions Mounjaro's Q1 sales and general diabetes info, but does not provide a combined sales figure of $79 billion for 2025.

menu_book

wikipedia NEUTRAL — Combine may refer to:
https://en.wikipedia.org/wiki/Combine

menu_book

wikipedia NEUTRAL — Combined may refer to: Alpine combined (skiing), the combination of slalom and downhill skiing as a single event Super combined (skiing) Nordic combined (skiing), the combination of cross country ski…
https://en.wikipedia.org/wiki/Combined

menu_book

wikipedia NEUTRAL — Combining may refer to: Combine harvester use in agriculture Combining capacity, in chemistry Combining character, in digital typography Combining form, in linguistics Combining grapheme joiner, Unic…
https://en.wikipedia.org/wiki/Combining

+ 3 more evidence sources

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.